✦ LIBER ✦

P.2.b.011 Copper as trait marker of major depressive episode

✍ Scribed by M. Fontana; R. Squitti; S. Cesaretti; M.G. Bevacqua; M. Ventriglia; M. Ribolsi; P.L. Zuppi; P.M. Rossini

Book ID: 118592747
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 66 KB
Volume: 16
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(06)70325-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.a.011 Major depressive episode chara

P.2.a.011 Major depressive episode characteristics according to the number of prior episodes: baseline analysis of the REPONSE cohort study

✍ P.M. Llorca; B. Gay; C. Spadone; S. Mouchabac; A. Crochard; P. Blin; F. Rouillon 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

P.2.b.052 Assessing the stress perceived

P.2.b.052 Assessing the stress perceived by caregivers of patients with major depressive episode: major depressive disorder versus bipolar disorder

✍ Oldani, L.; Dell'Osso, B.; Arici, C.; Dobrea, C.; Serati, M.; Altamura, A.C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P.2.b.011 Association of CRHR1 gene vari

P.2.b.011 Association of CRHR1 gene variation with bipolar disorder and major depressive disorder

✍ O. Szczepankiewicz; A. Leszczynska-Rodziewicz; J. Pawlak; A. Rajewska-Rager; M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

P.2.a.011 Efficacy of duloxetine in pain

P.2.a.011 Efficacy of duloxetine in painful symptoms with major depressive disorder

✍ J. Castaño; C. Garnier; D. Córcoles; L. Rodriguez; B. Diaz; L.M. Martin; A. Bulb 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

P.2.g.011 Significant effect of sertrali

P.2.g.011 Significant effect of sertraline on dopamine transporter (DAT) in major depression measured by b-CIT SPECT

✍ Z. Szabó; Z.S. Besenyi; M. Árgyelán; G. Eördegh; G.Y. Godó; A. Szkalicki; L. Páv 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Copper-transporting P-type adenosine tri

Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: Comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP

✍ Kentaro Nakayama; Atsuko Kanzaki; Kenji Ogawa; Kohji Miyazaki; Nouri Neamati; Yu 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 224 KB

## Abstract Intrinsic or acquired resistance to chemotherapy is the major obstacle to overcome in the treatment of patients with solid carcinoma. Cisplatin is one of the most effective chemotherapeutic agents for treating ovarian carcinoma. Recently, copper‐transporting P‐type adenosine triphosphat